Handel Better Therapeutics, Inc. - BTTX CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Handelsbetingelser
| Spænd | 0.0562 | ||||||||
|
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.025457% | ||||||||
|
Short position, gebyr natten over
Short position overnight fee
Gå til platform | 0.003235% | ||||||||
| Gebyr natten over, tid | 21:00 (UTC) | ||||||||
| Min. handlet mængde | 1 | ||||||||
| Valuta | USD | ||||||||
| Margen | 20% | ||||||||
| Aktiebørs | United States of America | ||||||||
| Kommission på handel | 0% |
*Information provided by Capital.com
Nøglestatistikker
| Tidligere luk* | 0.6683 |
| Åben* | 0.6671 |
| 1-Års Ændring* | -67.3% |
| Dagens Spænd* | 0.6486 - 0.7027 |
| 52-Ugers Spænd | 0.59-2.80 |
| Gennemsnitlig Volumen (10 dage) | 135.87K |
| Gennemsnitlig Volumen (3 måneder) | 2.90M |
| Market Cap | 21.89M |
| P/E-forhold | -100.00K |
| Udestående aktier | 31.73M |
| Omsætning | N/A |
| EPS | -1.67 |
| Dividend (Udbytte %) | N/A |
| Beta | -100.00K |
| Næste indtjeningsopgørelse | Aug 9, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Luk | Change | Change (%) | Åben | High | Low |
|---|---|---|---|---|---|---|
| May 26, 2023 | 0.6830 | 0.0159 | 2.38% | 0.6671 | 0.7263 | 0.6480 |
| May 25, 2023 | 0.6683 | -0.0257 | -3.70% | 0.6940 | 0.7422 | 0.6483 |
| May 24, 2023 | 0.7168 | -0.0290 | -3.89% | 0.7458 | 0.7459 | 0.6924 |
| May 23, 2023 | 0.7507 | 0.0054 | 0.72% | 0.7453 | 0.7651 | 0.7453 |
| May 22, 2023 | 0.7555 | 0.0201 | 2.73% | 0.7354 | 0.7942 | 0.7354 |
| May 19, 2023 | 0.7564 | 0.0013 | 0.17% | 0.7551 | 0.7747 | 0.7540 |
| May 18, 2023 | 0.7554 | -0.0015 | -0.20% | 0.7569 | 0.7845 | 0.7356 |
| May 17, 2023 | 0.7582 | 0.0126 | 1.69% | 0.7456 | 0.7797 | 0.7456 |
| May 16, 2023 | 0.7620 | -0.0388 | -4.85% | 0.8008 | 0.8037 | 0.7260 |
| May 15, 2023 | 0.7457 | -0.0580 | -7.22% | 0.8037 | 0.8136 | 0.7359 |
| May 12, 2023 | 0.7470 | 0.0310 | 4.33% | 0.7160 | 0.7749 | 0.7159 |
| May 11, 2023 | 0.7555 | -0.0823 | -9.82% | 0.8378 | 0.8571 | 0.7257 |
| May 10, 2023 | 0.8349 | 0.0215 | 2.64% | 0.8134 | 0.8716 | 0.7544 |
| May 9, 2023 | 0.8039 | 0.0391 | 5.11% | 0.7648 | 0.8137 | 0.7262 |
| May 8, 2023 | 0.7746 | -0.1165 | -13.07% | 0.8911 | 0.8911 | 0.6907 |
| May 5, 2023 | 0.9005 | 0.0042 | 0.47% | 0.8963 | 0.9298 | 0.8905 |
| May 4, 2023 | 0.9297 | -0.1353 | -12.70% | 1.0650 | 1.0653 | 0.8708 |
| May 3, 2023 | 1.0750 | 0.0017 | 0.16% | 1.0733 | 1.1041 | 1.0635 |
| May 2, 2023 | 1.0944 | 0.0095 | 0.88% | 1.0849 | 1.1233 | 1.0652 |
| May 1, 2023 | 1.0943 | -0.0281 | -2.50% | 1.1224 | 1.1332 | 1.0741 |
Better Therapeutics, Inc. Events
| Tid (UTC) (UTC) | Land | Begivenhed |
|---|---|---|
| Wednesday, August 9, 2023 | ||
| Tid (UTC) (UTC) 20:00 | Land US
| Begivenhed Q2 2023 Better Therapeutics Inc Earnings Release Q2 2023 Better Therapeutics Inc Earnings ReleaseForecast -Previous - |
| Monday, November 13, 2023 | ||
| Tid (UTC) (UTC) 21:00 | Land US
| Begivenhed Q3 2023 Better Therapeutics Inc Earnings Release Q3 2023 Better Therapeutics Inc Earnings ReleaseForecast -Previous - |
- Årlig
- Pr kvartal
| 2022 | 2021 | 2020 | |
|---|---|---|---|
| Total omsætning | 0 | 0 | 0 |
| Totale Driftsudgifter | 38.262 | 40.303 | 0.00169 |
| Other Operating Expenses, Total | 0.00169 | ||
| Driftsindtægter | -38.262 | -40.303 | -0.00169 |
| Netto Indkomst Før Skat | -39.753 | -40.488 | -0.00169 |
| Netto Indkomst Efter Skat | -39.76 | -40.335 | -0.00169 |
| Netto Indkomst Før Ekstra Ting | -39.76 | -40.335 | -0.00169 |
| Netto Indkomst | -39.76 | -40.335 | -0.00169 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -39.76 | -40.335 | -0.00169 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -39.76 | -40.335 | -0.00169 |
| Fortyndet Netto Indkomst | -39.76 | -40.335 | -0.00169 |
| Fortyndet Vægtet Gennemsnit Aktier | 23.5578 | 23.6027 | 7.5575 |
| Fortyndet EPS Uden Ekstraordinære Ting | -1.68776 | -1.70891 | -0.00022 |
| Dividends per Share - Common Stock Primary Issue | 0 | ||
| Fortyndet Normaliseret EPS | -1.68776 | -1.4406 | -0.00022 |
| Salgs/Generelle/Admin. Udgifter, Total | 21.822 | 11.124 | |
| Forskning & Udvikling | 16.44 | 19.436 | |
| Usædvanlig Udgift (Indkomst) | 0 | 9.743 | |
| Renteindkomst (Udgift), Netto Ikke-Drift | -1.491 | -0.185 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Total omsætning | 0 | 0 | 0 | 0 | 0 |
| Totale Driftsudgifter | 8.925 | 8.322 | 10.996 | 9.599 | 9.345 |
| Other Operating Expenses, Total | |||||
| Driftsindtægter | -8.925 | -8.322 | -10.996 | -9.599 | -9.345 |
| Renteindkomst (Udgift), Netto Ikke-Drift | -0.431 | -0.439 | -0.406 | -0.329 | -0.317 |
| Netto Indkomst Før Skat | -9.356 | -8.761 | -11.402 | -9.928 | -9.662 |
| Netto Indkomst Efter Skat | -9.357 | -8.765 | -11.405 | -9.928 | -9.662 |
| Netto Indkomst Før Ekstra Ting | -9.357 | -8.765 | -11.405 | -9.928 | -9.662 |
| Netto Indkomst | -9.357 | -8.765 | -11.405 | -9.928 | -9.662 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -9.357 | -8.765 | -11.405 | -9.928 | -9.662 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -9.357 | -8.765 | -11.405 | -9.928 | -9.662 |
| Fortyndet Netto Indkomst | -9.357 | -8.765 | -11.405 | -9.928 | -9.662 |
| Fortyndet Vægtet Gennemsnit Aktier | 23.8266 | 23.6315 | 23.6931 | 23.593 | 23.4132 |
| Fortyndet EPS Uden Ekstraordinære Ting | -0.39271 | -0.3709 | -0.48136 | -0.4208 | -0.41267 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Fortyndet Normaliseret EPS | -0.39271 | -0.3709 | -0.48136 | -0.4208 | -0.41267 |
| Salgs/Generelle/Admin. Udgifter, Total | 5.536 | 5.273 | 5.519 | 5.358 | 5.672 |
| Forskning & Udvikling | 3.389 | 3.049 | 5.477 | 4.241 | 3.673 |
| Usædvanlig Udgift (Indkomst) | 0 | 0 | 0 | 0 |
- Årlig
- Pr kvartal
| 2022 | 2021 | 2020 | |
|---|---|---|---|
| Totale Nuværende Aktiver | 18.446 | 45.251 | 0.08666 |
| Likvider og Kortsigtede Investeringer | 15.74 | 40.566 | 0.02476 |
| Cash | 0.02476 | ||
| Other Current Assets, Total | 0.21 | 0.276 | 0.06189 |
| Total Assets | 22.943 | 50.958 | 0.08666 |
| Total Current Liabilities | 13.494 | 4.733 | 0.06334 |
| Accrued Expenses | 5.927 | 3.21 | 0.00145 |
| Notes Payable/Short Term Debt | 0 | 0 | 0.06189 |
| Total Liabilities | 23.842 | 14.238 | 0.06334 |
| Total Long Term Debt | 10.348 | 9.505 | 0 |
| Total Equity | -0.899 | 36.72 | 0.02331 |
| Common Stock | 0.002 | 0.002 | 0.00014 |
| Additional Paid-In Capital | 110.602 | 108.461 | 0.02486 |
| Retained Earnings (Accumulated Deficit) | -111.503 | -71.743 | -0.00169 |
| Total Liabilities & Shareholders’ Equity | 22.943 | 50.958 | 0.08666 |
| Total Common Shares Outstanding | 23.851 | 23.6027 | 7.5575 |
| Likvider & Lignende | 15.74 | 40.566 | |
| Prepaid Expenses | 2.496 | 4.409 | |
| Property/Plant/Equipment, Total - Net | 0.121 | 0.082 | |
| Intangibles, Net | 3.888 | 5.077 | |
| Other Long Term Assets, Total | 0.488 | 0.548 | |
| Accounts Payable | 3.035 | 1.523 | |
| Long Term Debt | 10.348 | 9.505 | |
| Property/Plant/Equipment, Total - Gross | 0.178 | ||
| Accumulated Depreciation, Total | -0.057 | ||
| Current Port. of LT Debt/Capital Leases | 4.532 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Totale Nuværende Aktiver | 8.442 | 18.446 | 23.49 | 32.137 | 35.179 |
| Likvider og Kortsigtede Investeringer | 6.068 | 15.74 | 22.305 | 29.685 | 31.673 |
| Cash | |||||
| Prepaid Expenses | 1.968 | 2.496 | 1.123 | 2.38 | 3.242 |
| Total Assets | 12.808 | 22.943 | 28.221 | 37.103 | 40.291 |
| Long Term Investments | |||||
| Other Long Term Assets, Total | 0.483 | 0.488 | 0.488 | 0.487 | 0.488 |
| Total Current Liabilities | 13.64 | 13.494 | 9.312 | 6.141 | 3.567 |
| Accrued Expenses | 5.588 | 5.927 | 4.928 | 3.27 | 2.528 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 22.641 | 23.842 | 20.969 | 19.049 | 12.866 |
| Total Long Term Debt | 9.001 | 10.348 | 11.657 | 12.908 | 9.299 |
| Other Liabilities, Total | |||||
| Total Equity | -9.833 | -0.899 | 7.252 | 18.054 | 27.425 |
| Common Stock | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 |
| Additional Paid-In Capital | 111.025 | 110.602 | 109.988 | 109.385 | 108.828 |
| Retained Earnings (Accumulated Deficit) | -120.86 | -111.503 | -102.738 | -91.333 | -81.405 |
| Total Liabilities & Shareholders’ Equity | 12.808 | 22.943 | 28.221 | 37.103 | 40.291 |
| Total Common Shares Outstanding | 23.8523 | 23.851 | 23.7441 | 23.733 | 23.6086 |
| Payable/Accrued | |||||
| Likvider & Lignende | 6.068 | 15.74 | 22.305 | 29.685 | 31.673 |
| Other Current Assets, Total | 0.406 | 0.21 | 0.062 | 0.072 | 0.264 |
| Property/Plant/Equipment, Total - Net | 0.131 | 0.121 | 0.122 | 0.115 | 0.098 |
| Intangibles, Net | 3.752 | 3.888 | 4.121 | 4.364 | 4.526 |
| Accounts Payable | 2.513 | 3.035 | 1.255 | 1.088 | 0.735 |
| Long Term Debt | 9.001 | 10.348 | 11.657 | 12.908 | 9.299 |
| Current Port. of LT Debt/Capital Leases | 5.539 | 4.532 | 3.129 | 1.783 | 0.304 |
- Årlig
- Pr kvartal
| 2022 | 2021 | 2020 | |
|---|---|---|---|
| Netto indkomst/Startlinje | -39.76 | -40.335 | -0.00169 |
| Likvider Fra Driftsaktiviteter | -28.93 | -30.818 | -0.00024 |
| Ændringer i Driftskapital | 6.268 | -2.339 | 0.00145 |
| Likvider fra Financieringsaktiviteter | 5.284 | 72.332 | 0.025 |
| Financiering af Cash-Flow-Ting | 0 | 62.331 | -0.06189 |
| Udstedelse (Pensionering) af Aktier, Netto | 0.284 | 0.001 | 0.025 |
| Udstedelse (Pensionering) af Gæld, Netto | 5 | 10 | 0.06189 |
| Netto Ændring i Likviditet | -24.826 | 40.443 | 0.02476 |
| Likvider Fra Driftsaktiviteter | 2.729 | 1.619 | |
| Deferred Taxes | 0 | -0.152 | |
| Ikke-Likvide Ting | 1.833 | 10.389 | |
| Likvid Rente Betalt | 1.325 | 0.085 | |
| Likvider fra Investeringsaktiviteter | -1.18 | -1.071 | |
| Kapitaludgifter | -1.18 | -1.071 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -9.357 | -39.76 | -30.995 | -19.59 | -9.662 |
| Cash From Operating Activities | -8.716 | -28.93 | -22.593 | -15.57 | -8.855 |
| Non-Cash Items | 0.41 | 1.833 | 1.384 | 0.787 | 0.375 |
| Changes in Working Capital | -0.524 | 6.268 | 5.01 | 1.919 | -0.231 |
| Cash From Investing Activities | -0.521 | -1.18 | -0.82 | -0.457 | -0.039 |
| Other Investing Cash Flow Items, Total | |||||
| Cash From Financing Activities | -0.435 | 5.284 | 5.152 | 5.146 | 0.001 |
| Financing Cash Flow Items | 0 | 0 | 0 | 0 | |
| Issuance (Retirement) of Stock, Net | 0 | 0.284 | 0.152 | 0.146 | 0.001 |
| Issuance (Retirement) of Debt, Net | -0.435 | 5 | 5 | 5 | |
| Net Change in Cash | -9.672 | -24.826 | -18.261 | -10.881 | -8.893 |
| Cash From Operating Activities | 0.755 | 2.729 | 2.008 | 1.314 | 0.663 |
| Deferred Taxes | 0 | 0 | 0 | 0 | |
| Cash Interest Paid | 0.495 | 1.325 | 0.87 | 0.462 | 0.219 |
| Capital Expenditures | -0.521 | -1.18 | -0.82 | -0.457 | -0.039 |
| Cash Taxes Paid | 0 |
| Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
|---|---|---|---|---|---|---|
| Perry (David P) | Individual Investor | 53.1606 | 16868581 | 6404566 | 2023-04-12 | LOW |
| Georgianna Maule-Ffinch 2015 Trust | Individual Investor | 11.4598 | 3636364 | 3636364 | 2023-04-10 | |
| Appelbaum (Kevin J) | Individual Investor | 7.5847 | 2406719 | -6250 | 2023-04-10 | LOW |
| Mountain Crest Capital LLC | Corporation | 4.375 | 1388250 | 0 | 2023-04-10 | LOW |
| Farallon Capital Management, L.L.C. | Hedge Fund | 2.203 | 699042 | -114514 | 2023-03-31 | MED |
| Armanino (Andrew J) | Individual Investor | 1.4739 | 467692 | 303030 | 2023-04-10 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.3818 | 438479 | 3700 | 2023-03-31 | LOW |
| Parker (Geoffrey M) | Individual Investor | 1.2491 | 396363 | 303030 | 2023-04-10 | LOW |
| Maule-Ffinch (Georgianna) | Individual Investor | 0.9238 | 293150 | 0 | 2023-04-10 | LOW |
| Karbe (Frank L) | Individual Investor | 0.9216 | 292424 | 242424 | 2023-04-10 | MED |
| Berman Mark A | Individual Investor | 0.7309 | 231939 | 0 | 2023-04-10 | LOW |
| Carmona (Richard H. M.D.) | Individual Investor | 0.4841 | 153619 | 0 | 2023-04-10 | LOW |
| Wynholds (Kristin) | Individual Investor | 0.3114 | 98819 | 0 | 2023-04-10 | LOW |
| Heinen (Mark) | Individual Investor | 0.2773 | 88004 | 1 | 2023-04-10 | MED |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.2523 | 80054 | 798 | 2023-03-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.18 | 57109 | 0 | 2023-03-31 | LOW |
| Susquehanna International Group, LLP | Investment Advisor | 0.1497 | 47516 | -6473 | 2023-03-31 | MED |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.1424 | 45200 | 0 | 2023-03-31 | LOW |
| Zamirowski (Justin) | Individual Investor | 0.1163 | 36913 | 36913 | 2022-05-27 | |
| Millennium Management LLC | Hedge Fund | 0.0837 | 26556 | 14932 | 2023-03-31 | HIGH |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com Group530K+
Handlende
87K+
Månedlkige, aktive klienter
$46M+
Månedlig investeringsvolumen
$31M+
Hævet hver måned
Handelslommeregner
Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).
Handelskurtage
0
- 1:1
Gearing
1:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Handelsstørrelse (Gearing x Investering):
Åben
Luk
Short Long
Better Therapeutics, Inc. Company profile
Om Better Therapeutics, Inc.
Better Therapeutics, Inc, tidligere Mountain Crest Acquisition Corp II, beskæftiger sig med at tilbyde receptpligtig digital terapeutisk platform til behandling af kardiometaboliske sygdomme. Selskabet udvikler behandlinger til at vende sygdomsudviklingen, forbedre livskvaliteten og informere kliniske beslutninger. Virksomheden udvikler receptpligtig digital terapi, der leverer en ny form for adfærdsterapi og skaber feedbackmekanismer ved hjælp af fjernovervågede og patientgenererede data. Virksomhedens kliniske udviklingspipeline omfatter BT-001, BT-002, BT-003, BT-004 og BT-005. Virksomheden er ved at evaluere BT-001 i en central undersøgelse som en receptpligtig behandling, der anvendes under lægens tilsyn til personer med ukontrolleret type 2-diabetes. Virksomheden udvikler Nutritional Cognitive Behavioral Therapy (Nutritional CBT), som er en ny form for adfærdsterapi under udvikling til behandling af patienter med type 2-diabetes og andre kardiometaboliske sygdomme.
| Industry: | Biotechnology & Medical Research (NEC) |
548 Market St. #49404
SAN FRANCISCO
CALIFORNIA 94101
US
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 520.000+ handlende over hele verden, der valgte at handle hos Capital.com